Diseases
Explore disease pages that summarize symptoms, diagnostic context, and related care topics.
Diseases starting with A (4,253)
T373X5A
Adverse effect of other antiprotozoal drugs, initial encounter
T373X5S
Adverse effect of other antiprotozoal drugs, sequela
T373X5D
Adverse effect of other antiprotozoal drugs, subsequent encounter
T43595A
Adverse effect of other antipsychotics and neuroleptics, initial encounter
T43595S
Adverse effect of other antipsychotics and neuroleptics, sequela
T43595D
Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
T50A95A
Adverse effect of other bacterial vaccines, initial encounter
T50A95S
Adverse effect of other bacterial vaccines, sequela
T50A95D
Adverse effect of other bacterial vaccines, subsequent encounter
T44995A
Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
T44995S
Adverse effect of other drug primarily affecting the autonomic nervous system, sequela
T44995D
Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter
T48295A
Adverse effect of other drugs acting on muscles, initial encounter
T48295S
Adverse effect of other drugs acting on muscles, sequela
T48295D
Adverse effect of other drugs acting on muscles, subsequent encounter
T50995A
Adverse effect of other drugs, medicaments and biological substances, initial encounter
T50995S
Adverse effect of other drugs, medicaments and biological substances, sequela
T50995D
Adverse effect of other drugs, medicaments and biological substances, subsequent encounter
T385X5A
Adverse effect of other estrogens and progestogens, initial encounter
T385X5S
Adverse effect of other estrogens and progestogens, sequela
T385X5D
Adverse effect of other estrogens and progestogens, subsequent encounter
T45695A
Adverse effect of other fibrinolysis-affecting drugs, initial encounter
T45695S
Adverse effect of other fibrinolysis-affecting drugs, sequela
T45695D
Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
T41295A
Adverse effect of other general anesthetics, initial encounter
T41295S
Adverse effect of other general anesthetics, sequela
T41295D
Adverse effect of other general anesthetics, subsequent encounter
T38995A
Adverse effect of other hormone antagonists, initial encounter
T38995S
Adverse effect of other hormone antagonists, sequela
T38995D
Adverse effect of other hormone antagonists, subsequent encounter
T38895A
Adverse effect of other hormones and synthetic substitutes, initial encounter
T38895S
Adverse effect of other hormones and synthetic substitutes, sequela
T38895D
Adverse effect of other hormones and synthetic substitutes, subsequent encounter
T474X5A
Adverse effect of other laxatives, initial encounter
T474X5S
Adverse effect of other laxatives, sequela
T474X5D
Adverse effect of other laxatives, subsequent encounter
T40695A
Adverse effect of other narcotics, initial encounter
T40695S
Adverse effect of other narcotics, sequela
T40695D
Adverse effect of other narcotics, subsequent encounter
T398X5A
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
T398X5S
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
T398X5D
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
T39395A
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
T39395S
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
T39395D
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
T402X5A
Adverse effect of other opioids, initial encounter
T402X5S
Adverse effect of other opioids, sequela
T402X5D
Adverse effect of other opioids, subsequent encounter
T443X5A
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
T443X5S
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
T443X5D
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
T441X5A
Adverse effect of other parasympathomimetics [cholinergics], initial encounter
T441X5S
Adverse effect of other parasympathomimetics [cholinergics], sequela
T441X5D
Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter
T458X5A
Adverse effect of other primarily systemic and hematological agents, initial encounter
T458X5S
Adverse effect of other primarily systemic and hematological agents, sequela
T458X5D
Adverse effect of other primarily systemic and hematological agents, subsequent encounter
T40995A
Adverse effect of other psychodysleptics [hallucinogens], initial encounter
T40995S
Adverse effect of other psychodysleptics [hallucinogens], sequela
T40995D
Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
T43695A
Adverse effect of other psychostimulants, initial encounter
T43695S
Adverse effect of other psychostimulants, sequela
T43695D
Adverse effect of other psychostimulants, subsequent encounter
T438X5A
Adverse effect of other psychotropic drugs, initial encounter
T438X5S
Adverse effect of other psychotropic drugs, sequela
T438X5D
Adverse effect of other psychotropic drugs, subsequent encounter
T378X5A
Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
T378X5S
Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela
T378X5D
Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
T40495A
Adverse effect of other synthetic narcotics, initial encounter
T40495S
Adverse effect of other synthetic narcotics, sequela
T40495D
Adverse effect of other synthetic narcotics, subsequent encounter
T368X5A
Adverse effect of other systemic antibiotics, initial encounter
T368X5S
Adverse effect of other systemic antibiotics, sequela
T368X5D
Adverse effect of other systemic antibiotics, subsequent encounter
T498X5A
Adverse effect of other topical agents, initial encounter
T498X5S
Adverse effect of other topical agents, sequela
T498X5D
Adverse effect of other topical agents, subsequent encounter
T50Z95A
Adverse effect of other vaccines and biological substances, initial encounter
T50Z95S
Adverse effect of other vaccines and biological substances, sequela
T50Z95D
Adverse effect of other vaccines and biological substances, subsequent encounter
T50B95A
Adverse effect of other viral vaccines, initial encounter
T50B95S
Adverse effect of other viral vaccines, sequela
T50B95D
Adverse effect of other viral vaccines, subsequent encounter
T496X5A
Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
T496X5S
Adverse effect of otorhinolaryngological drugs and preparations, sequela
T496X5D
Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
T480X5A
Adverse effect of oxytocic drugs, initial encounter
T480X5S
Adverse effect of oxytocic drugs, sequela
T480X5D
Adverse effect of oxytocic drugs, subsequent encounter
T360X5A
Adverse effect of penicillins, initial encounter
T360X5S
Adverse effect of penicillins, sequela
T360X5D
Adverse effect of penicillins, subsequent encounter
T467X5A
Adverse effect of peripheral vasodilators, initial encounter
T467X5S
Adverse effect of peripheral vasodilators, sequela
T467X5D
Adverse effect of peripheral vasodilators, subsequent encounter
T50A15A
Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
T50A15S
Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
T50A15D
Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
T433X5A
Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter